The novel approach of the medication represents a significant breakthrough in the handling of diabetes mellitus type 2. Unlike existing medications, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatide-peptide460401.howeweb.com/42652936/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment